Evidence map›Paper›PMID 19889773›Full record

ArticleJournal of virology2010

The open reading frame 3a protein of severe acute respiratory syndrome-associated coronavirus promotes membrane rearrangement and cell death.

Eric C Freundt, Li Yu, Cynthia S Goldsmith, Sarah Welsh, Aaron Cheng, Boyd Yount, Wei Liu, Matthew B Frieman, Ursula J Buchholz, Gavin R Screaton and 6 more

Open access · greenAbstract read
In one paragraph

Article in Journal of virology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 92 papers.

0numbers the graph read from it
0cells of the map it votes in
92citing papers in PubMed
1.3field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

92 citing papers in PubMed, 152 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Nonlytic Egress and Transmission in the Virus World.Annual review of biochemistry · 2025
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. The role of cell death in SARS-CoV-2 infection.Signal transduction and targeted therapy · 2023
    Review

32 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 9 institutions in 3 countries.

Eric C FreundtLaboratory of Immunology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892, USA.
Li Yu
Cynthia S Goldsmith
Sarah Welsh
Aaron Cheng
Boyd Yount
Wei Liu
Matthew B Frieman
Ursula J Buchholz
Gavin R Screaton
Jennifer Lippincott-Schwartz
Sherif R Zaki
Xiao-Ning Xu
Ralph S Baric
Kanta Subbarao
Michael J Lenardo
Laboratory of Molecular Genetics · PLNational Institute of Allergy and Infectious Diseases · USUniversity of North Carolina at Chapel Hill · USEunice Kennedy Shriver National Institute of Child Health and Human Development · USCenters for Disease Control and Prevention · USHammersmith Hospital · GBJohn Radcliffe Hospital · GBNational Institutes of Health · USUniversity of Oxford · GB

Funding

Organization and Dynamics of Endomembrane Pathways and OrganellesZIAHD001609 · NICHD · EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT · PI BONIFACINO, JUAN · 2009 to 2019
$16.2M
Paramyxoviruses as Vaccine Vectors Against Highly Pathogenic VirusesZIAAI000938 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI BUCHHOLZ, URSULA · 2009 to 2025
$12.4M
Molecular Pathways of Programmed Cell Death And Viral CytopathicityZIAAI000718 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI SU, HELEN · 2009 to 2024
$4.5M
Vaccines, Immunoprophylaxis, and Immunotherapy for SARSZIAAI000934 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI SUBBARAO, KANTA · 2009 to 2012
$1.5M
SARS Reverse GeneticsR01AI059136 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI BARIC, RALPH S · 2004 to 2008
$1.4M
Intramural NIH HHSMedical Research Council G0400720Medical Research Council G0801508Medical Research Council MC_U137881015NIAID NIH HHS AI059136NIAID NIH HHS R01 AI059136
6 · The paper itself

Abstract

The genome of the severe acute respiratory syndrome-associated coronavirus (SARS-CoV) contains eight open reading frames (ORFs) that encode novel proteins. These accessory proteins are dispensable for in vitro and in vivo replication and thus may be important for other aspects of virus-host interactions. We investigated the functions of the largest of the accessory proteins, the ORF 3a protein, using a 3a-deficient strain of SARS-CoV. Cell death of Vero cells after infection with SARS-CoV was reduced upon deletion of ORF 3a. Electron microscopy of infected cells revealed a role for ORF 3a in SARS-CoV induced vesicle formation, a prominent feature of cells from SARS patients. In addition, we report that ORF 3a is both necessary and sufficient for SARS-CoV-induced Golgi fragmentation and that the 3a protein accumulates and localizes to vesicles containing markers for late endosomes. Finally, overexpression of ADP-ribosylation factor 1 (Arf1), a small GTPase essential for the maintenance of the Golgi apparatus, restored Golgi morphology during infection. These results establish an important role for ORF 3a in SARS-CoV-induced cell death, Golgi fragmentation, and the accumulation of intracellular vesicles.

Indexed as

Cell MembraneHost-Pathogen InteractionsADP-Ribosylation Factor 1AnimalsCell DeathChlorocebus aethiopsCytoplasmic VesiclesGene DeletionGolgi ApparatusHumansSevere acute respiratory syndrome-related coronavirusTransfectionVero CellsViral Structural ProteinsViroporin ProteinsADP-Ribosylation Factor 1ORF3A protein, SARS coronavirusViral Structural ProteinsViroporin Proteins

Identifiers

PMID19889773
PMCPMC2798367
OpenAlexW2070979531

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.